Last reviewed · How we verify
NCT06913595
Low Molecular Weight Heparin vs Direct Oral Anticoagulant After Bariatric Surgery
Phase 1 trial testing Direct Oral Anticoagulant. in Deep Venous Thrombosis in 100 participants. Participants enrolled and being followed up; not accepting new ones.
25 October 2025
Quick facts
| Lead sponsor | Cairo University |
|---|---|
| Phase | Phase 1 |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 100 |
| Start date | 25 March 2024 |
| Primary completion | 25 October 2025 |
| Estimated completion | 1 November 2025 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Direct Oral Anticoagulant.
- Low Molecular Weight Heparine — full drug profile →
Conditions studied
- Deep Venous Thrombosis — all drugs for Deep Venous Thrombosis →
Sponsor
Cairo University
Who can join
Eligibility, any sex, with Deep Venous Thrombosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Extended Venous Thromboemboism Prophylaxis After Bariatric Surgeries: A Comparison Of Low Molecular Weight Heparin With Direct Oral Anticoagulant
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06913595
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Deep Venous Thrombosis
Currently open trials in the same condition.
- NCT07399977 — Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism · NA · recruiting
- NCT04211181 — CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism · NA · recruiting
- NCT05701917 — DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis · NA · recruiting
- NCT04924322 — Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies · Phase 2, PHASE3 · recruiting
Other Cairo University trials
Trials by the same sponsor.
- NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
- NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
- NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
- NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
- NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06913595 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cairo University
- Last refreshed: 26 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06913595.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing